Background: Chronic kidney disease (CKD) is recognized as a common condition that elevates the risk of atherosclerotic cardiovascular disease (CVD). Evidence suggests that increased oxidative stress is an emerging key mechanism of atherosclerosis in CKD. One recent study reported that indoxyl sulfate (IS), a uremic toxin derived from dietary protein, could cause vascular disorder, however, little is known about the mechanism involved. The present study examined the signaling pathway that is activated by IS to induce monocyte chemoattractant protein-1 (MCP-1), which plays an important role in the development of atherosclerosis, in cultured human umbilical vein endothelial cells (HUVEC).
hronic kidney disease (CKD) is now recognized as a common condition that elevates the risk of cardiovascular disease (CVD), along with kidney failure and other complications; patients with CKD are considered to be in the 'highest risk group' for subsequent CVD events. 1-3 Therefore, there has been rapidly growing interest in the association between kidney disease, the risk of death, and CVD. Multiple possible explanations exist for this association. Accelerated atherosclerosis in CKD has consistently been implicated, in part because of a higher prevalence of traditional risk factors such as diabetes, hypertension, and dyslipidemia; however, these traditional risk factors have not fully accounted for the high risk of atherosclerosis in CKD patients. One recent study supported the idea that non-traditional risk factors, such as oxidative stress, inflammation, and decreased nitric oxide (NO) bioavailability, play a pivotal role in the development of atherosclerosis in individuals with CKD. 4 Notably, increased oxidative stress is emerging as a key mechanism of atherosclerosis in CKD. The increased production of reactive oxygen species (ROS) and other radicals by endothelial, vascular smooth muscle, and adventitial cells regulates the expression of a large number of transcription factors, which cause endothelial dysfunction and eventual atherosclerotic lesions. 4, 5 In CKD patients, progressive deterioration of renal function might lead to accumulation of uremic toxins, which can induce oxidative stress and favor development of atherosclerosis. 6,7 A recent clinical study showed that p-cresol, a
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uremic toxin that induces endothelial dysfunction, is associated with mortality in patients treated with hemodialysis (HD). 8 Another study reported indoxyl sulfate (IS), which is a uremic toxin that accelerates the progression of CKD, 9-11 showed a significant negative correlation with high-density lipoprotein cholesterol in 224 HD patients, using multivariate analysis. 12 Thus, uremic toxins appear to correlate with the progression of atherosclerosis.
IS is one of the organic anions that is metabolized in the liver from indole, which is produced by intestinal bacteria as a metabolite of tryptophan. 13, 14 IS is normally excreted into the urine and exists at high concentrations in the serum of patients with progressive CKD. 12,15, 16 Recent studies reported that IS might be associated with endothelial dysfunction. [17] [18] [19] [20] Although it is thought that IS plays an important role in the pathophysiological conditions in patients with CKD, little is known about the mechanism involved.
To investigate the effect of IS on endothelial cells, we focused on ROS production. ROS can regulate intracellular kinase activities by reversibly inactivating phosphatases and can activate transcription factors including nuclear factor-κB (NF-κB), which in turn leads to expression of inflammatory cytokines such as monocyte chemoattractant protein-1 (MCP-1), which plays a crucial role in the recruitment of monocytes into the arterial wall. 21 According to recent studies, ROS derived from NADPH oxidase is involved in the regulation of MCP-1 gene expression in endothelial cells. 19, 22 The aim of this study was to determine if IS induced ROS production by activating NADPH oxidase, leading to the induction of MCP-1 expression in human umbilical vein endothelial cells (HUVEC), and to clarify the mechanisms involved.
Methods

Reagents
Medium 199, endothelial cell growth supplement, IS, PD98059, SB203580, PDTC, and apocynin were purchased from Sigma -Aldrich (St Louis, MO, USA). Fetal bovine serum was purchased from Biological Industries (Haemek, Israel).
Cell Culture HUVEC were purchased from Dainippon Sumitomo Pharmacy (Osaka, Japan) and cultured in a type I collagen-coated plate (Asahi Glass, Tokyo, Japan) at 37°C and 5% CO2 in medium 199 supplemented with 10% fetal bovine serum, 10 mmol/L glutamine, 100 μg/ml heparin, 20 μg/ml endothelial growth factor, 100 μg/ml gentamicin, and 100 μg/ml amphotericin B. Cells were used for experiments between passages 4 and 7.
Determining MCP-1 Secretion HUVEC were incubated with IS (125 μg/ml) for 1, 8 and 24 h. The supernatants were collected, and the released MCP-1 in the culture medium was quantified by sandwich enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN, USA), according to protocol of the manufacturer.
RNA Extraction and Reverse Transcription (RT)-Polymerase
Chain Reaction (PCR) Analysis MCP-1 mRNA expression was studied using RT and comparative PCR. Total RNA was extracted from HUVEC using ISOGEN (Nippon Gene, Toyama, Japan). The total RNA isolated by this method was undegraded and free of protein and DNA contamination. The sequences of the sense and antisense primers used for amplification were MCP-1: 5'-ACT-GAAGCTCGATACTCTC-3', 5'-CTTGGGTTGTGGAGTG-AG-3' and GAPDH: 5'-ACCACCTGGTGCTCAGTGTA-3', 5'-ACCATCTTCCAGGAGCGAGA-3'.
The PCR products were separated by electrophoresis on agarose gel in the presence of ethidium bromide and visualized under ultraviolet light.
Real-Time RT-PCR
MCP-1 and NADPH oxidase 4 (Nox4) mRNA expression was analyzed with quantitative real-time RT-PCR using an iQ5 Real-Time PCR Detection System (Bio-Rad, CA, USA) and the iScript One-Step RT-PCR Kit with SYBR Green (Bio-Rad). The sequences of the sense and antisense primers used for amplification were MCP-1: 5'-TCTCAGTGCAGA-GGCTCGCGA-3', 5'-GAGTGAGTGTTCAAGTCTTCG-3'; Nox4: 5'-CAGAAGGTTCCAAGCAGGAG-3', 5'-GTTGA-GGGCATTCACCAGAT-3' and GAPDH: GACCCCTTGA-TTGACCTCAAC-3', 5'-CTTCTCCATGGTGGTGAAGA-3'. The fluorescent signal from SYBR Green was detected immediately after the extension step and the threshold cycle (Ct) was recorded. The Ct value from GAPDH served as an internal control for normalization.
Immunoblotting
To obtain total protein, HUVEC were homogenized in cold lysis buffer [ The supernatant contained nuclear proteins. The protein concentration of each sample was measured using a Bio-Rad detergent-compatible protein assay. Equal amounts of protein extract were separated by 10% sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis (PAGE) and transferred to a polyvinyldienefluoride (PVDF) membrane (GE Healthcare, UK). The membrane was blocked for 1 h at room temperature with Tris-buffered saline containing 0.05% Tween 20 and 5% bovine serum albumin. After washing with TBS-T, the membranes were incubated overnight with phospho-ERK1/2 antibody (1:2,000), phospho-p38 MAPK antibody (1:2,000), NF-κBp65 antibody (1:2,000) (Cell signaling Technology Inc, Beverly, MA, USA), or β-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Bands were visualized using horseradish peroxidase-conjugated antirabbit IgG (1:5,000) (GE Healthcare) and the ECL Plus sys-MASAI N et al.
tem (GE Healthcare). Images were acquired in a ChemiDoc XRS System (Bio-Rad) and analyzed with PDQuest software (Bio-Rad).
Cellular Superoxide Detection
Cultured HUVEC were rinsed in PBS and incubated with Dihydroethidium (DHE: 10 μmol/L) (Sigma -Aldrich) in PBS for 30 min at 37°C in a humidified chamber protected from light. Reaction with O2· -oxidizes DHE to ethidium bromide, which binds to DNA in the nucleus and fluoresces red. 23 A 543-nm He-Ne laser was used in combination with a 560-nm long-pass filter to detect ethidium bromide.
Statistical Analysis
Results were expressed as mean values ± standard error of the mean (SEM). Comparisons among groups were performed by one-way ANOVA analysis. Values of P<0.05 were considered significant. Results shown are representative of at least 3 independent experiments.
Results
IS Increases MCP-1 Expression in HUVEC
It is well known that MCP-1 plays an important role in the development of atherosclerosis; however, little is known about the pathophysiological role of IS on MCP-1 in endothelial cells. We, therefore, examined how IS affected MCP-1 expression in HUVEC. At first, to determine if IS induces MCP-1 expression in vascular endothelial cells, HUVEC were incubated for 1 h in media with different concentrations of IS. Treatment of HUVEC with IS at concentrations from 25 to 125 μg/ml caused a dose-dependent increase in MCP-1 mRNA expression compared with the controls (Figures 1A,  B) . We performed further experiments at concentrations of 125 μg/ml, because the mean and maximal plasma concentrations of IS in uremic patients were reported to be 50 μg/ml and 240 μg/ml, respectively, 24 and 125 μg/ml of IS significantly increased the expression of MCP-1 mRNA. IS induction of MCP-1 mRNA was time dependent, increasing within 1 h and peaking at 24 h (Figures 1C,D) .
Next, we measured the release of MCP-1 protein into culture medium with an ELISA. IS stimulated the secretion of MCP-1 in HUVEC at 8 h and 24 h compared with control ( Figure 1E ).
NADPH Oxidase-Derived ROS Mediates IS-Induced MCP-1 Expression in HUVEC
As several reports have shown that ROS induces MCP-1 expression in endothelial cells, 19, 22 and that NADPH oxidase is a major source of superoxide in vascular cells and monocytes, 25 we examined the effect of apocynin (600 μmol/L), a specific NADPH oxidase inhibitor, on IS-induced ROS production and MCP-1 expression. As shown in Figure 2A , HUVEC treated with IS for 2 min exhibited increased superoxide production compared with the controls, but pretreatment with apocynin for 30 min significantly reduced their ROS production, indicating that IS-induced ROS production in HUVEC was most likely derived from NADPH oxidase activity. It is reported that Nox2 and Nox4, kinds of the NADPH oxidase family, are present in vascular endothelial Expression of MCP-1 by Indoxyl Sulfate cells, 26 and that Nox4 functions as the major catalytic component of an endothelial NADPH oxidase. 27 To confirm that NADPH oxidase plays an important role in ROS generation in HUVEC, we examined the expression of Nox2 and Nox4 mRNA using real-time RT-PCR. As shown in Figure 2B , IS increased Nox4 mRNA expression in HUVEC within 2 min, whereas it did not increase Nox2 mRNA expression (data not shown). Furthermore, we observed that apocynin abolished IS-induced increases in MCP-1 mRNA (Figures 2C, D) and protein secretion (Figure 2E) . Taken together, these results suggest that NADPH oxidase-derived ROS mediates ISinduced MCP-1 expression in HUVEC.
IS-Induced NADPH Oxidase-Derived ROS Phosphorylates ERK1/2 and p38 in HUVEC The mitogen-activated protein kinase (MAPK) family is comprised of key regulatory proteins that control the cellular response to growth, apoptosis, and stress signals, and it is known to be crucially involved in the induction of pro-inflammatory processes, including MCP-1 production in endothelial cells. 28, 29 Therefore, we investigated the underlying intracellular pathways affected by IS treatment of HUVEC, by determining how components of the MAPK family, ERK1/2 and p38, were activated. Figure 3A shows that treatment of HUVEC with IS caused a time-dependent phosphorylation of ERK1/2 with maximal levels occurring at 5 min and a return to basal levels by 60 min. As was the case for ERK1/2, p38 was phosphorylated by IS, and reached a peak at 2 min ( Figure 3A) . These results suggest the ERK1/2 and p38 pathways, which are associated with inflammation, are activated by IS in HUVEC.
It is known that ROS derived from NADPH oxidase can function as a signaling molecule to mediate specific cellular responses including MAP cascades. 25 Thus, we examined the effect of apocynin on IS-induced activation of ERK1/2 and p38. As shown in Figure 3B , the IS-induced increase in ERK1/2 and p38 phosphorylation at 5 min was markedly reduced in HUVEC pretreated with apocynin for 30 min. These data indicate that NADPH oxidase-derived ROS, induced by IS, activates ERK1/2 and p38 in HUVEC.
Both ERK1/2 and p38 Are Involved in IS-Induced MCP-1 Expression in HUVEC
To explore the role of ERK1/2 and p38 in MCP-1 induction 
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by IS, we conducted experiments using specific inhibitors of ERK1/2 and p38. Pretreatment of HUVEC with the inhibitors of either ERK1/2 (PD98059, 30 μmol/L) or p38 (SB203580, 10 μmol/L), partially suppressed IS-induced MCP-1 mRNA expression and protein secretion. Interestingly, pretreatment of HUVEC with both PD98059 and SB20358 markedly supressed IS-induced MCP-1 mRNA and protein (Figures 4  A-C) . Taken together, these results suggest that ERK1/2 and p38 independently regulate IS-induced expression of MCP-1.
MAPK-Activated NF-κB Regulates IS-Induced MCP-1 Expression in HUVEC
It is now well appreciated that NF-κB is a redox-sensitive transcription factor that induces a number of cytokines including MCP-1. 19,25, 28 The major form of NF-κB is composed of a dimer of p50 and p65 subunits, which is sequestered in the cytoplasm through its tight association with specific inhibitory proteins, IκB. When a cell receives various stimulations, IκB is activated through phosphorylation. After dissociating from IκB, p65/p50 is transported into the nucleus and NF-κB target genes are transcribed. 30 To evaluate the role of IS in NF-κB activation, we followed the nuclear translocation of p65 in HUVEC. Western blotting of nuclear extracts revealed that IS caused nuclear translocation of p65 within 30 min, which was detectable until at least 2 h after treatment (Figure 5A) , suggesting that NF-κB is activated by IS. According to a recent study, some oxidants, including oxLDL, activate NF-κB via MAPK. 22 Therefore, we examined whether inhibitors of ERK1/2 and p38 affected NF-κB activation by IS. As expected, the combination of PD98059 and SB203580 blocked IS-induced translocation of p65 into the nucleus (Figure 5B) . These results suggest that IS activates NF-κB via phosphorylation of ERK1/2 and p38.
Finally, to investigate if the NF-κB pathway was involved 
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in IS-induced MCP-1 expression, HUVEC were pretreated for 30 min with PDTC (10 μmol/L), an inhibitor of NF-κB. 31 As shown in Figures 5C-E , PDTC inhibited IS-induced increases in both MCP-1 mRNA and protein, indicating that IS increases MCP-1 expression by activating NF-κB.
Discussion
The present study demonstrated that exposure of HUVEC to IS induces ROS production via NADPH oxidase, activates MAPK and NF-κB, and results in MCP-1 expression. These finding have considerable implications for atherosclerosis in the setting of CKD. CKD is defined by the clinical practice guidelines from the National Kidney Foundation as either: (1) kidney damage for ≥3 months, as confirmed by kidney biopsy or markers of kidney damage, with or without a decrease in glomerular filtration rate (GFR), or (2) a GFR <60 ml · min -1 · 1.73 m -2 for ≥3 months, with or without kidney damage. 1 The prevalence of stage 1 to 4 CKD in the USA increased from 10.0% in 1988-1994 to 13.1% in 1999-2004. 32 As CVD is frequently associated with CKD, and individuals with CKD are more likely to die of CVD than to develop kidney failure, 3 CKD is recognized as a worldwide health problem, and the role of individual cardiovascular risk factors in CKD are important. In individuals with CKD, CVD risk factors are classified as either 'traditional' or 'non-traditional'. Traditional risk factors, such as older age, diabetes mellitus, and hypertension, are highly prevalent in CKD. But, these traditional risk factors have not fully accounted for the high risk of cardiovascular events in CKD patients, and growing evidence supports the idea that non-traditional risk factors contribute to CVD. Non-traditional risk factors include oxidative stress, inflammation, hyperhomocysteinemia, and decreased NO bioavailability. Among these, oxidative stress is involved in every step of atherosclerosis and is known to be the primary mediator that induces vascular injury.
Recently, in vitro and in vivo studies have suggested that uremic solutes, which accumulate as GFR reduces, are involved in vascular disorder. 12-14,17-19,33-35 IS is a protein-bound uremic solute that is metabolized by the liver from indole, which is a tryptophan metabolite produced by the intestinal flora, and IS serum concentrations reportedly correlate with renal function. 8, 15 Moreover, previous studies showed that IS enhanced ROS production and induced cellular toxicity in endothelial cells, 14,18,19,33 vascular smooth muscle cells, 34,35 glomerular mesangial cells, 10 and renal tubular cells. 11 Tumur and Niwa found that IS inhibited NO production and reduced cell viability by inducing ROS through induction of Nox4, a component of endothelial NADPH oxidase, in endothelial cells. 17 Tumur et al also found that IS upregulates expression of ICAM-1 and MCP-1 by oxidative stress- MASAI N et al.
induced NF-κB activation in endothelial cells. 19 Dou et al found that IS enhanced ROS production, increased NADPH oxidase activity, and decreased glutathione levels in endothelial cells. 33 Although IS stimulates the production of ROS in vascular cells, little is known about its downstream signaling mechanism in human vascular endothelial cells. Therefore, the present study was designed to investigate the mechanisms underlying the modulation of MCP-1, which is a key player in the development of atherosclerosis, by IS. At first we examined the effect of IS on MCP-1 mRNA and protein expression in HUVEC. IS significantly upregulated MCP-1 mRNA expression in a dose-and time-dependent manner, which accompanied the increased release of MCP-1 protein into the culture medium. A previous study reported that uremic patients had approximately a 50-fold increase in serum levels of IS, compared to healthy individuals, and that mean and maximal uremic concentrations were approximately 50 μg/ml and 240 μg/ml, respectively. 24 As shown in Figures 1A and B, we observed that 25 μg/ml of IS upregulated MCP-1 expression, suggesting that IS causes endothelial damage not only in uremic patients but also in patients with more mild renal dysfunction.
Next, we analyzed the mechanisms responsible for ISinduced MCP-1 expression in HUVEC. Our results showed 
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that based on DHE staining, IS immediately increased intracellular ROS production in HUVEC. ROS production was blocked by apocynin, a specific NADPH oxidase inhibitor, which was accompanied by a marked reduction in MCP-1 expression.
The family of NADPH oxidases plays an important role in the production of ROS in response to receptor agonists such as growth factors or inflammatory cytokines. 26 Nox2 and Nox4 are known to present in vascular endothelial cells. 36 Our results showed that IS rapidly increased Nox4, but not Nox2, mRNA expression in HUVEC. These results are in agreement with previous findings that IS induced the expression of Nox4 mRNA but not Nox2 in HUVEC by Tumur and Niwa. 17 Taken together, these observations indicate that IS-induced MCP-1 expression is mediated by ROS derived from NADPH oxidase, a major source of ROS in endothelial cells. 37 Furthermore, our results suggest Nox4 has important role for the production of ROS by IS.
We also found that IS-induced NADPH oxidase-derived ROS activates ERK1/2 and p38 in HUVEC, because pharmacological inhibition of NADPH oxidase markedly reduced IS-induced phosphorylation. According to a previous study by Yamamoto et al, 35 IS also activates ERK1/2 in vascular smooth muscle cells (VSMCs). Shimizu et al also demonstrated IS induces ROS production with activation of ERK1/2 and p38 in VSMCs. 38 Therefore, it seems that IS induces vascular damage not only in endothelial cells but also in VSMCs by activating MAPK. To further investigate if phosphorylation of ERK1/2 and p38 by ROS regulates IS-induced MCP-1 expression, we performed experiments with ERK1/2 and/or p38 inhibitors. We found that either PD98059 or SB203580 partially reduced IS-induced MCP-1 expression, but, more interestingly, combined treatment with both markedly supressed MCP-1 expression. These data suggest that the ROS-activated ERK1/2 and p38 pathways mediate IS-induced MCP-1 upregulation, synergistically.
To further clarify the downstream mechanisms by which phosphorylation of ERK1/2 and p38 regulated IS-induced MCP-1 expression, we performed experiments focused on NF-κB signaling. We demonstrated that IS induced nuclear translocation of p65, a subunit of NF-κB, within 30 min in HUVEC. To our knowledge, few reports have documented the association between IS and the MAPK/NF-κB pathway. To elucidate the mechanisms by which IS activated NF-κB, cells were pretreated with PD98059 and SB20358. We observed that IS-induced activation of NF-κB was blocked by a combination of PD98059 and SB20358, suggesting that IS activates NF-κB through phosphorylation of ERK1/2 and p38. Furthermore, inhibition of NF-κB by PDTC significantly reduced both MCP-1 mRNA and protein expression, suggesting NF-κB mediates induction of MCP-1 expression.
In summary, the current study revealed that IS exposure increased NADPH oxidase-derived ROS, which in turn, activated the MAPK (both ERK1/2 and p38)/NF-κB pathway in HUVEC, leading to induction of MCP-1, a key player in the initiation of atherosclerosis. These data clearly demonstrate that IS has significant inflammatory and pro-atherosclerotic properties in HUVEC. These findings also raise the possibility that IS plays an important pathophysiological role in the development of atherosclerotic CVD in individuals with CKD.
